Biochemical Evaluation by Confirmatory Tests after Unilateral Adrenalectomy for Primary Aldosteronism

Table 3

Characteristics of patients before and after Adx.

Variables	Before Adx	After Adx	value
Number of patients	16
Age at Adx (year)
Female/male sex	9/7
After Adx evaluation time (month)
Presence of hypokalemia (%)	50	0
SBP (mmHg)			0.002
DBP (mmHg)			0.032
Medication (defined daily dose)			<0.001
eGFR (mL/min/1.73 m^2)			<0.001
Basal PRA (ng/mL/h)			<0.001
Basal PAC (ng/dL)			<0.001
Basal ARR			<0.001
U-Aldo (μg/day)			<0.001
AVS (yes/no)	15/1
AVS (yes/no)	13/3
Tumor detected by CT (yes/no)	12/4
Side for adrenalectomy (left/right)	10/6
Histological diagnosis (adenoma/cortical nodule)		14/2

Adx: unilateral adrenalectomy; SBP: systolic blood pressure; DBP: diastolic blood pressure; Medication: antihypertensive medication; eGFR: estimated glomerular filtration rate; PRA: plasma renin activity; PAC: plasma aldosterone concentration; ARR: aldosterone-renin ratio; U-Aldo: 24 h urine aldosterone; AVS: adrenal venous sampling; LR: lateralized ratio; CR: contralateral ratio; CT: computed tomography. Data are presented as deviation. The Wilcoxon signed-rank test or Fisher’s exact test is performed. value < 0.05.